Funds and ETFs Vivani Medical, Inc.

Equities

VANI

US92854B1098

Medical Equipment, Supplies & Distribution

End-of-day quote Nasdaq 06:00:00 2024-05-22 pm EDT 5-day change 1st Jan Change
1.63 USD -7.39% Intraday chart for Vivani Medical, Inc. -17.26% +59.80%
Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It is engaged in the development of the Company’s lead programs NPM-115 and NPM-119, is a GLP-1 implant candidates for the treatment of chronic weight management and patients with type 2 diabetes, respectively. Its other pipeline product candidates include NPM-139, and OKV-119. It uses this platform technology to develop and commercialize drug implant candidates for the treatment of chronic disease and medication non-adherence. It operates through two segments: Biopharm Division and Neuromodulation Division. The Company’s implant technology, which it refers as NanoPortal, utilizes a space-efficient design that allows a miniaturized implant to provide many months of therapeutic delivery of potent molecules.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.63 USD
Average target price
8 USD
Spread / Average Target
+390.80%
Consensus
  1. Stock Market
  2. Equities
  3. VANI Stock
  4. Funds and ETFs Vivani Medical, Inc.